Quarterly Result31 Jan 2026, 04:01 pm
Nath Bio-Genes Reports Q3 and Nine Months Financial Results for 2025
AI Summary
Nath Bio-Genes (India) Ltd. has announced its financial results for the quarter and nine months ended on 31st December 2025. The company's revenue from operations stands at 6596.11 lakhs for the quarter and 38590.36 lakhs for the nine months period. The net profit for the period is 4214.01 lakhs. The company's financial results were reviewed by the Audit Committee on 30th January 2026 and approved by the Board of Directors at its meeting held on 31st January 2026.
Key Highlights
- Revenue from operations for the quarter is 6596.11 lakhs
- Revenue from operations for the nine months period is 38590.36 lakhs
- Net profit for the period is 4214.01 lakhs
- Financial results reviewed by the Audit Committee on 30th January 2026
- Financial results approved by the Board of Directors on 31st January 2026
Price Impact
More from NATHBIOGEN
More in Quarterly Result